JP2023541840A5 - - Google Patents
Info
- Publication number
- JP2023541840A5 JP2023541840A5 JP2023515364A JP2023515364A JP2023541840A5 JP 2023541840 A5 JP2023541840 A5 JP 2023541840A5 JP 2023515364 A JP2023515364 A JP 2023515364A JP 2023515364 A JP2023515364 A JP 2023515364A JP 2023541840 A5 JP2023541840 A5 JP 2023541840A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutical composition
- group
- formula
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20382804.1A EP3967684A1 (en) | 2020-09-14 | 2020-09-14 | Antitumoral ascorbic acid esters |
| EP20382804.1 | 2020-09-14 | ||
| PCT/EP2021/075104 WO2022053679A1 (en) | 2020-09-14 | 2021-09-13 | Antitumoral ascorbic acid esters |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023541840A JP2023541840A (ja) | 2023-10-04 |
| JP2023541840A5 true JP2023541840A5 (https=) | 2024-09-24 |
| JP7805651B2 JP7805651B2 (ja) | 2026-01-26 |
Family
ID=72709280
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023515364A Active JP7805651B2 (ja) | 2020-09-14 | 2021-09-13 | 抗腫瘍アスコルビン酸エステル |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230278974A1 (https=) |
| EP (2) | EP3967684A1 (https=) |
| JP (1) | JP7805651B2 (https=) |
| KR (1) | KR20230088718A (https=) |
| CN (1) | CN116724028B (https=) |
| AU (1) | AU2021339010A1 (https=) |
| CA (1) | CA3191119A1 (https=) |
| ES (1) | ES3006988T3 (https=) |
| MX (1) | MX2023002970A (https=) |
| WO (1) | WO2022053679A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4676461A1 (en) * | 2023-03-09 | 2026-01-14 | Mastery Biotech Co., Ltd. | Conjugate compound comprising 13-cis-retinoic acid and ascorbic acid |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2831395B2 (ja) * | 1989-09-12 | 1998-12-02 | ハリマ化成株式会社 | アスコルビン酸エステル |
| JP3781877B2 (ja) * | 1997-10-03 | 2006-05-31 | 株式会社ムック | アスコルビン酸誘導体またはその塩、および医薬 |
| CN101550119B (zh) | 2009-05-11 | 2012-05-30 | 无锡宏瑞生物医药科技有限公司 | 芳基(乙)丙酸抗坏血酸酯,其制备方法及含有它们的药物 |
| JP2016104708A (ja) | 2014-12-01 | 2016-06-09 | 参天製薬株式会社 | アスコルビン酸誘導体を含有する非水性注射剤及びデポ形成方法 |
| JP6588764B2 (ja) | 2015-01-26 | 2019-10-09 | 章博 田井 | 抗腫瘍剤 |
| CN106139151A (zh) * | 2016-04-29 | 2016-11-23 | 陈西敬 | 抗坏血酸棕榈酰酯与抗肿瘤药物协同作用的药物组合物 |
| CA3031979A1 (en) * | 2016-08-01 | 2018-02-08 | IC-MedTech Corp. | Ascorbic acid, quinone compound, and sodium glucose cotransporter inhibitor for treating cancer |
-
2020
- 2020-09-14 EP EP20382804.1A patent/EP3967684A1/en not_active Withdrawn
-
2021
- 2021-09-13 MX MX2023002970A patent/MX2023002970A/es unknown
- 2021-09-13 US US18/043,620 patent/US20230278974A1/en active Pending
- 2021-09-13 JP JP2023515364A patent/JP7805651B2/ja active Active
- 2021-09-13 WO PCT/EP2021/075104 patent/WO2022053679A1/en not_active Ceased
- 2021-09-13 CA CA3191119A patent/CA3191119A1/en active Pending
- 2021-09-13 EP EP21777302.7A patent/EP4211123B1/en active Active
- 2021-09-13 ES ES21777302T patent/ES3006988T3/es active Active
- 2021-09-13 AU AU2021339010A patent/AU2021339010A1/en active Pending
- 2021-09-13 KR KR1020237012737A patent/KR20230088718A/ko active Pending
- 2021-09-13 CN CN202180062720.9A patent/CN116724028B/zh active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020169171A5 (https=) | ||
| JP2015051994A5 (https=) | ||
| JP2023510746A5 (https=) | ||
| JP2010540556A5 (https=) | ||
| JP2004529963A5 (https=) | ||
| JP2022533958A5 (https=) | ||
| JP2023518776A (ja) | シクロスポリン誘導体の調製 | |
| CN1198802C (zh) | 具有抗增殖活性的查耳酮类化合物 | |
| CN120623091A (zh) | 用于制备具有经取代的苯基或吡啶基部分的serd三环化合物的方法 | |
| JP2023541840A5 (https=) | ||
| JP7229482B2 (ja) | 新規アミド系化合物、並びにそれを用いたＰｉｎ１阻害剤、炎症性疾患の治療剤及び癌の治療剤 | |
| FR2840301A1 (fr) | Derives de phenyl-cyclohexyl-propanolamine, leur preparation et leur applicaton en therapeutique | |
| JP2023529828A5 (https=) | ||
| CN110698378A (zh) | 2-(羟基-(甲基环丙基)苯基氨基)-1-哌嗪基乙酮衍生物的制备方法 | |
| RU2395517C2 (ru) | Новый пиримидиновый нуклеозид или его соль | |
| JP7163439B2 (ja) | カリケアマイシン誘導体を合成するための中間体および方法 | |
| JP2022521474A5 (https=) | ||
| JP2023541040A5 (https=) | ||
| JP2979054B2 (ja) | 骨関節疾患の治療に有用なｎ−〔｛４，５−ジヒドロキシ−及び４，５，８−トリヒドロキシ−９，１０−ジヒドロ−９，１０−ジオキソ−２−アントラセン−イル｝カルボニル〕アミノ酸 | |
| JP2025507308A5 (https=) | ||
| CN1118166A (zh) | 法呢基：蛋白质转移酶抑制剂作为抗癌药 | |
| JP2022545181A5 (https=) | ||
| JP2023545151A (ja) | アミノコンブレタスタチン誘導体及びその応用 | |
| CN1229374C (zh) | 用于抑制细胞增殖的取代的二吲哚基马来酰亚胺 | |
| JP4621429B2 (ja) | 乳酸誘導体 |